Analyst Ratings for Viracta Therapeutics (VIRX)

VIRX Rating Summary

  |   Expand Research on VIRX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6 / 10   Percentile Rank: 64%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/27/2024 Rodman & Renshaw N/A Downgrade Neutral
(Buy)		 0.25
(3.50)		 0.24
(0.08)		 -66.67% Details
8/16/2024 Leerink Partners Andrew Berens Downgrade Market Perform
(Outperform)		 3.00
(5.00)		 0.38
(0.08)		 -78.95% Details